Literature DB >> 21669253

Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: response of normal versus autoreactive Treg-deficient T cells.

Zhi Huang1, Danielle Meola, John M Petitto.   

Abstract

Emerging data from our lab and others suggested that dysregulation of the brain's endogenous neuroimmunological milieu may occur with the loss of brain IL-2 gene expression and be involved in initiating processes that lead to CNS autoimmunity. We sought to test our working hypothesis that IL-2 deficiency induces endogenous changes in the CNS that play a key role in eliciting T cell homing into the brain. To accomplish this goal, we used an experimental approach that combined mouse congenic breeding and immune reconstitution. In congenic mice without brain IL-2 (two IL-2 KO alleles) that were reconstituted with a normal wild-type immune system, the loss of brain IL-2 doubled the number of T cells that trafficked into the brain in all regions quantified (hippocampus, septum, and cerebellum) compared to mice with two wild-type brain IL-2 alleles and a wild-type peripheral immune system. Congenic mice with normal brain IL-2 (two wild-type IL-2 alleles) that were immune reconstituted with autoreactive Treg-deficient T cells from IL-2 KO mice developed the expected peripheral autoimmunity (splenomegaly) and had a comparable doubling of T cell trafficking into the hippocampus and septum, whereas they exhibited an additional twofold proclivity for the cerebellum over the septohippocampal regions. Unlike brain trafficking of wild-type T cells, the increased homing of IL-2 KO T cells to the cerebellum was independent of brain IL-2 gene expression. These findings demonstrate that brain IL-2 deficiency induces endogenous CNS changes that may lead to the development of brain autoimmunity, and that autoreactive Treg-deficient IL-2 KO T cells trafficking to the brain could have a proclivity to induce cerebellar neuropathology.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669253      PMCID: PMC3150161          DOI: 10.1016/j.neulet.2011.05.230

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  46 in total

1.  Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis.

Authors:  Xiaojun Wu; Weihong Pan; Yi He; Hung Hsuchou; Abba J Kastin
Journal:  J Neuroimmunol       Date:  2010-04-28       Impact factor: 3.478

2.  Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release.

Authors:  Diego Gomez-Nicola; Beatriz Valle-Argos; Manuel Nieto-Sampedro
Journal:  Glia       Date:  2010-02       Impact factor: 7.452

3.  Interleukin-2 deficiency-induced T cell autoimmunity in the mouse brain.

Authors:  Zhi Huang; Daniel J Dauer; Grace K Ha; Mark H Lewis; John M Petitto
Journal:  Neurosci Lett       Date:  2009-07-10       Impact factor: 3.046

4.  Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis.

Authors:  Rahul Sharma; Angela Chiao-Ying Ju; John T Kung; Shu Man Fu; Shyr-Te Ju
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 5.  Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology.

Authors:  Richard M Ransohoff
Journal:  Immunity       Date:  2009-11-20       Impact factor: 31.745

6.  Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study.

Authors:  Jane Yip; Jean Jacques Soghomonian; Gene J Blatt
Journal:  Autism Res       Date:  2009-02       Impact factor: 5.216

7.  Cerebral microvascular IL15 is a novel mediator of TNF action.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Reas S Khan; Abba J Kastin
Journal:  J Neurochem       Date:  2009-08-31       Impact factor: 5.372

8.  Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.

Authors:  Evridiki Sgouroudis; Alexandre Albanese; Ciriaco A Piccirillo
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Johannes Vogt; Friedemann Paul; Orhan Aktas; Kathrin Müller-Wielsch; Jan Dörr; Susanne Dörr; B Suman Bharathi; Robert Glumm; Christoph Schmitz; Harry Steinbusch; Cedric S Raine; Michael Tsokos; Robert Nitsch; Frauke Zipp
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

10.  Activation of the maternal immune system alters cerebellar development in the offspring.

Authors:  Limin Shi; Stephen E P Smith; Natalia Malkova; Doris Tse; Yixuan Su; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2008-08-09       Impact factor: 7.217

View more
  5 in total

1.  Loss of cholinergic phenotype in septohippocampal projection neurons: relation to brain versus peripheral IL-2 deficiency.

Authors:  Danielle M Meola; Zhi Huang; Michael King; John M Petitto
Journal:  Neurosci Lett       Date:  2013-02-13       Impact factor: 3.046

2.  Loss of Neuronal Phenotype and Neurodegeneration: Effects of T Lymphocytes and Brain Interleukin-2.

Authors:  Danielle Meola; Zhi Huang; Grace K Ha; John M Petitto
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-06

3.  Dissecting the effects of endogenous brain IL-2 and normal versus autoreactive T lymphocytes on microglial responsiveness and T cell trafficking in response to axonal injury.

Authors:  Zhi Huang; Danielle Meola; John M Petitto
Journal:  Neurosci Lett       Date:  2012-08-16       Impact factor: 3.046

4.  Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.

Authors:  John M Petitto; Jesse D Cushman; Zhi Huang
Journal:  J Neurol Disord       Date:  2015

5.  Myeloid and T Cell-Derived TNF Protects against Central Nervous System Tuberculosis.

Authors:  Nai-Jen Hsu; Ngiambudulu M Francisco; Roanne Keeton; Nasiema Allie; Valérie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  Front Immunol       Date:  2017-02-23       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.